Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis

Infect Immun. 1995 Apr;63(4):1611-4. doi: 10.1128/iai.63.4.1611-1614.1995.

Abstract

Borrelia burgdorferi is the causative agent of Lyme disease. In the mouse model, protection is correlated with the development of antibodies to a major outer surface protein, OspA. In this study, we expressed OspA in an attenuated strain of Salmonella typhimurium and tested the efficacy of the transformed strain in protecting against disease. We show that mice inoculated by gavage developed high titers of anti-OspA antibodies and were protected against an intradermal challenge with the spirochete.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Animals
  • Antigens, Surface / immunology*
  • Bacterial Outer Membrane Proteins / immunology*
  • Bacterial Vaccines / administration & dosage
  • Bacterial Vaccines / immunology*
  • Borrelia burgdorferi Group / immunology
  • Lipoproteins*
  • Lyme Disease / prevention & control*
  • Mice
  • Mice, Inbred C3H
  • Salmonella typhimurium / immunology
  • Vaccines, Attenuated / immunology
  • Vaccines, Synthetic / immunology

Substances

  • Antigens, Surface
  • Bacterial Outer Membrane Proteins
  • Bacterial Vaccines
  • Lipoproteins
  • OspA protein
  • Vaccines, Attenuated
  • Vaccines, Synthetic